NFKB1 and breast carcinoma: Constitutive activation of NF-κB could be confirmed in cancer in general, and in breast cancer in particular, supporting overall tumor progression, drug resistance, invasiveness, epithelial-to-mesenchymal-transition (EMT) and the promotion of hormone-independent growth [17,25,26,27,28].